[Topics for antiangiogenic therapy for glioblastoma].
Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Shingo
S
Takano
Akira
A
Matsumura
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000628:therapy; D005909:Glioblastoma / Q000098:blood supply / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000628:therapy*; D015398:Signal Transduction / Q000187:drug effects
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents